Literature DB >> 1155220

Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine.

F Fyhrquist, K Kurppa, M Huuskonen.   

Abstract

Clonidine, 225 mug a day, has been given orally for 3 months to 15 patients with essential hypertension. Mean BP was reduced from 159/107 to 143/87 mmHg. The antihypertensive effect of the drug was dissociated from changes in plasma renin activity (PRA) during clonidine treatment. PRA levels decreased initially in 6 patients with the highest PRA values before treatment, but then increased again. In 6 patients with lower pretreatment PRA levels, PRA rose continuously. Opposite patterns of 24-hour urinary sodium excretion were observed in these arbitrary subgroups. The antihypertensive effect of clonidine in essential hypertension appears to be independent of changes in PRA.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155220     DOI: 10.1111/j.0954-6820.1975.tb04951.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

1.  [Behaviour of plasma renin activity during long-term treatment with propranolol (author's transl)].

Authors:  H Witzgall; D Klaus; B Braun; H Ebel; J Zehner
Journal:  Klin Wochenschr       Date:  1977-04-01

2.  Effect of baroreflex activation therapy on renal sodium excretion in patients with resistant hypertension.

Authors:  Mark Lipphardt; Michael J Koziolek; Luca-Yves Lehnig; Ann-Kathrin Schäfer; Gerhard A Müller; Stephan Lüders; Manuel Wallbach
Journal:  Clin Res Cardiol       Date:  2019-04-06       Impact factor: 5.460

3.  Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors:  T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

Review 4.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  Clonidine withdrawal. Mechanism and frequency of rebound hypertension.

Authors:  G G Geyskes; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

6.  Effect of guanfacine on blood pressure and renin activity in hypertensive patients.

Authors:  J Rosenthal
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

7.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.